Background Accurate and rapid detection of tuberculosis (TB) and drug resistance are
critical for improving patient care and decreasing the spread of TB. Xpert® MTB/RIF assay …

Molecular typing has revolutionized epidemiological studies of infectious diseases,
including those of a mycobacterial etiology. With the advent of fingerprinting techniques …

ABSTRACT WHO-endorsed phenotypic drug susceptibility testing (DST) methods for
Mycobacterium tuberculosis are assumed to be the gold standard for identifying rifampin …

Background Xpert MTB/RIF and Xpert MTB/RIF Ultra (Xpert Ultra) are World Health
Organization (WHO)‐recommended rapid tests that simultaneously detect tuberculosis and …

Tuberculosis ranges among the leading causes of morbidity and mortality worldwide. A
diagnostic approach to a patient with possible tuberculosis includes a detailed medical …

Background One of the challenges facing the tuberculosis (TB) control programmes in
resource-limited settings is lack of rapid techniques for detection of drug resistant TB …

Diariamente novos artigos científicos sobre tuberculose (TB) são publicados em todo
mundo. No entanto, é difícil para o profissional sobrecarregado na rotina de trabalho …

Global tuberculosis (TB) eradication is undermined by increasing prevalence of emerging
resistance to available drugs, fuelling ongoing demand for more complex diagnostic and …

Globally, tuberculosis (TB) still remains a major public health problem. India is a high TB
burden country contributing to 26 per cent of global TB burden. During 1944-1980, TB …

With the availability of new diagnostics and supporting policies, the next major step is
translation of policy into practice. The impact of new tests will depend largely on the extent of …